153 results
Page 6 of 8
6-K
EX-99.1
ka9nkkq1
8 Feb 19
Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
8:05am
6-K
EX-99.1
6apytl
9 Jan 19
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
8:05am
6-K
EX-99.1
aefoaix6
31 Dec 18
Current report (foreign)
8:00am
6-K
EX-99.1
26wzph98371fp yu8n
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
8:01am
6-K
EX-99.1
ff6mo4lj5y70rs
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
wpd81ic
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
q64uf5v8
7 Nov 18
Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
8:01am
6-K
EX-99.1
0ik8z9t5le
23 Oct 18
Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option
9:21am
POS AM
tewqlja7
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
255uy6tug8 v2fbjms
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
6-K
EX-99.1
9lkf5q9jczhg5efbjc
9 Oct 18
Current report (foreign)
5:21pm
424B5
w2s o4zi5wj4khcs
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
fln8xvq tj4i3aiv4
4 Oct 18
Acasti Pharma Prices C$24 Million Underwritten Offering
11:00am
6-K
EX-99.1
j3myn
4 Oct 18
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
11:00am
6-K
EX-99.1
lop93nt9z
3 Oct 18
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
5:15pm
6-K
EX-99.1
t4i2zf
3 Oct 18
Acasti Pharma Announces Public Equity Offering
5:15pm
424B5
zkg9atsx
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
61dtt
1 Oct 18
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
5:00pm
6-K
EX-99.1
klso2pwbwl4i svt8td
24 Sep 18
Acasti Pharma Appoints Jean-François Boily as Vice President of Finance
8:05am
6-K
EX-99.1
e1ejj9 itry
14 Aug 18
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019
1:04pm